Agoracom Blog

#AI tools could improve fake news detection by analyzing users’ interactions and comments – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:12 PM on Tuesday, June 2nd, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company is working with US Government agencies on Covid19 and Coronavirus fake news and disinformation. The company also obtained the rights to import and sell COVID-19 test kits from South Korea – Click here for more info.

AI tools could improve fake news detection by analyzing users’ interactions and comments

  • According to the Pew Research Center, approximately 68% of U.S. adults got their news from social media in 2018 — which is worrisome, considering misinformation about the pandemic, for instance, continues to go viral
  • Companies from Facebook and Twitter to Google are pursuing automated detection solutions, but fake news remains a moving target, owing to its topical and stylistic diversity

By: Kyle Wiggers

In a paper published on the preprint server Arxiv.org, researchers affiliated with Microsoft and Arizona State University propose an approach to detecting fake news that leverages a technique called weak social supervision. They say that by enabling the training of fake news-detecting AI even in scenarios where labeled examples aren’t available, weak social supervision opens the door to exploring how aspects of user interactions indicate that news might be misleading.

According to the Pew Research Center, approximately 68% of U.S. adults got their news from social media in 2018 — which is worrisome, considering misinformation about the pandemic, for instance, continues to go viral. Companies from Facebook and Twitter to Google are pursuing automated detection solutions, but fake news remains a moving target, owing to its topical and stylistic diversity.

Building on a study published in April, the coauthors of this latest work suggest that weak supervision — where noisy or imprecise sources provide data labeling signals — could improve fake news detection accuracy without requiring fine-tuning. To this end, they built a framework dubbed Tri-relationship for Fake News (TiFN) that models social media users and their connections as an “interaction network” to detect fake news.

Interaction networks describe the relationships between entities like publishers, news stories, and users. Given an interaction network, TiFN aims to embed different types of entities, based on the observation that people tend to interact with like-minded friends. In making its predictions, the framework also accounts for the fact that connected users are more likely to share similar interests in news pieces, that publishers with a high degree of political bias are more likely to publish fake news, and that users with low credibility are more likely to spread fake news.VB Transform 2020 Online – July 15-17. Join leading AI executives: Register for the free livestream.

To test whether TiFN’s weak social supervision could help to detect fake news effectively, the team validated it against a Politifact data set containing 120 true news pieces and 120 verifiably fake pieces shared among 23,865 users. Versus baseline detectors that consider only news content and some social interactions, the researchers report that TiFN achieved between 75% to 87% accuracy, even with a limited amount of weak social supervision (within 12 hours after the news was published).

In another experiment — involving a separate custom framework called Defend — the researchers sought to use news sentences and user comments explaining why a piece of news is fake as a weak supervision signal. Tested on a second Politifact data set consisting of 145 true news and 270 fake news pieces with 89,999 comments from 68,523 users on Twitter, they say Defend achieved 90% accuracy.

“[W]ith the help of weak social supervision from publisher-bias and user-credibility, the detection performance is better than those without utilizing weak social supervision. We [also] observe that when we eliminate [the] news content component, user comment component, or the co-attention for news contents and user comments, the performances are reduced. [This] indicates capturing the semantic relations between the weak social supervision from user comments and news contents is important,” wrote the researchers. “[W]e can see [that] within a certain range more weak social supervision leads to a larger performance increase, which shows the benefit of using weak social supervision.”

Source: https://venturebeat.com/2020/06/01/ai-tools-could-improve-fake-news-detection-by-analyzing-users-interactions-and-comments/

#Beats Turns To #Esports – SPONSOR: Esports Entertainment Group $GMBL $DKNG $PENN $GAN $ESPO

Posted by AGORACOM-JC at 3:51 PM on Tuesday, June 2nd, 2020

SPONSOR: Esports Entertainment Group (GMBL:NASDAQ) – Millions of people from around the world tune in to watch teams of video game players compete with each other. In first quarter 2020, YouTube reported 1.1 billion hours watched, an increase of 13% when compared to fourth quarter 2019. Wagering on Esports is projected to hit $23 BILLION this year although that number will likely be eclipsed due to the recent pandemic. Esports Entertainment Group is the next generation online gambling company designed for the purpose of facilitating as much of this wagering as possible.  LEARN MORE.

Beats Turns To Esports

  • Rather than using NBA stars to promote a new line of colors in its Powerbeats Pro line, Beats by Dr. Dre has turned to esports organization FaZe Clan
  • A drone delivered the headphones to FaZe Clan’s Los Angeles headquarters Monday in an event broadcast by the organization’s Instagram account to its 9 million followers.

By Pat Evans

Apple’s Beats by Dr. Dre have been a staple in the NBA community for years, but with the league sidelined, the headphone brand is making a new push into esports. Rather than using NBA stars to promote a new line of colors in its Powerbeats Pro line, Beats by Dr. Dre has turned to esports organization FaZe Clan.

A drone delivered the headphones to FaZe Clan’s Los Angeles headquarters Monday in an event broadcast by the organization’s Instagram account to its 9 million followers. In comparison, the brand used NBA stars James Harden and Anthony Davis to debut the Powerbeats Pro line last year.

Beats by Dr. Dre Chief Marketing Officer Chris Thorne cited the hiatus of traditional sports and the thriving esports industry as reasons for the move, while noting the market of 2.4 billion global gamers and the interest of Gen Z and millennials should drive continued demand for the headphones.

Beats by Dr. Dre is the latest high-end brand – including Lamborghini and MAC Cosmetics  â€“ to move marketing money to esports, a reflection of the growing influence of video games. In the first quarter of 2020, U.S. consumers spent a record $10.9 billion on video games.

Source: https://frntofficesport.com/beats-by-dre-esports/

Primo Nutraceuticals Inc. $PRMO.ca Receives Approval to Sell its Hand Sanitizer on #Amazon.com $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:20 AM on Tuesday, June 2nd, 2020
  • Announced that it has received approval from Amazon to sell their Primo Lemon Hand Sanitizer in Amazon’s Personal Safety & Household category
  • Through continued perseverance and multiple discussions with customer care, and due to Primo meeting all the required criteria as a licensed establishment with a product that has been licensed and approved by Health Canada, Primo was finally granted permission from Amazon to sell its hand sanitizer on their website.

VANCOUVER, British Columbia, June 02, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has received approval from Amazon to sell their Primo Lemon Hand Sanitizer in Amazon’s Personal Safety & Household category.

In response to the increasing demand for hand sanitizers in Canada, approximately two months ago Primo filled out an online application to sell its hand sanitizer on Amazon. Primo was granted a Seller Central account but was initially denied the ability to list its hand sanitizer, as Amazon was no longer approving new listings in this category. In early March, Amazon began restricting the types of sellers on its third-party Marketplace platform that are able to sell health and sanitation products, such as: face masks, hand sanitizer, disinfecting wipes/ sprays, isopropyl alcohol, among other products. 

Through continued perseverance and multiple discussions with customer care, and due to Primo meeting all the required criteria as a licensed establishment with a product that has been licensed and approved by Health Canada, Primo was finally granted permission from Amazon to sell its hand sanitizer on their website.

The approval by Amazon could not have come at a better time for the company as its first shipment of hand sanitizer was picked up at their manufacturer on Friday, May 29th, 2020 with an expected delivery of later this week.

In reference to the company’s press release dated March 24th, Primo will be handing out the hand sanitizer as well as promotional samples for procurement departments in the healthcare industry across Canada to essential workers.

The company will also be taking the opportunity to hand out samples to potential customers that are interested in purchasing the hand sanitizer in bulk orders.

To view the product brochure, please visit: https://www.primoceuticals.com/shop#!/Primo-Lemon-Hand-Sanitizer-60/p/197662415/category=0

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC. 

“Andy Jagpal” 

President and Director 

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected] 

To learn more about what this news means to the shareholders visit: 

Shop: www.primoceuticals.com 

www.twitter.com/prmonutra 

https://t.me/PrimoNutraceuticals

www.thrivecbd.org 

www.beautykitchen.net 

www.drinkdefy.com 

Corporate: www.primonutraceuticals.com 

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

New Age Metals $NAM.ca River Valley Drilling Continues to Intersect and Expand #Palladium Mineralization at the Pine Zone $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN #PGM

Posted by AGORACOM-JC at 9:13 AM on Tuesday, June 2nd, 2020
  • Palladium mineralization is still open to expansion by drilling to the east, particularly testing a strong IP chargeability high located about 400 metres along strike, and also by drilling down-dip to the south
  • Hole PZ-20-04 intersected 1101 ppb Pd+Pt+Au (1.250 g/t PdEq) over 12 metres from 50 metres downhole, including 1361 ppb Pd+Pt+Au over 8 metres in the Pine Zone; and
  • Hole PZ-20-01 intersects 1287 ppb Pd+Pt+Au (1.477 g/t PdEq) over 3 metres from 168 metres downhole in the Pine Zone

June 2nd, 2020 – Rockport, Canada – New Age Metals Inc. (TSXV:NAM); (OTC:NMTLF); (FSE:P7J) – The Company is pleased to announce new results from the 2020 Phase 1 exploration drilling program at its 100% owned River Valley Palladium Project. This district-scale land package and large mineral resource is located near the City of Sudbury, Ontario,
and its world-class mining and processing facilities.

Chairman and CEO Harry Barr stated; “Phase 1 of the 2020 drill program was successful in extending the known limits of the Pine Zone Palladium mineralization 50 metres up-dip to the north and 50 metres along strike to the east. The Palladium mineralization is still open to expansion by drilling to the east, particularly testing a strong IP chargeability high located about 400 metres along strike, and also by drilling down-dip to the south (see Figure 1). The 2020 drilling was also successful at broadly establishing the presence of Palladium mineralization at the connection of the Pine Zone to the Dana North Zone.”

This release describes results from 1,685.5 metres of drilling in 8 holes completed in Q2 2020 on the Pine Zone-Dana North Zone area of the multi-million-ounce River Valley Palladium Project. The objectives of the drill program were threefold: 1) expand the limits of the Pine Zone Palladium mineralization; 2) investigate possible connection of the Pine Zone to the Dana North Zone at depth; and 3) test Palladium mineralization continuity within the 2019 Block Model.
The drill program was successful in extending the Pine Zone mineralization up-dip to the north and along strike to the east, thereby demonstrating opportunity to further expand the Mineral Resources in support of a Prefeasibility Study in 2021-2022.

The Pine Zone was discovered by drilling an IP chargeability high in 2015-2016, in the footwall to the main River Valley deposit at the Dana North Zone, at the north end of the Property and under the main access road. Seven holes were drilled into the Pine Zone-T3 area in 2015-2016 and 14 in 2017 plus the 5 in 2020 for a total of 26 holes. Before 2015, seven holes had been drilled through the Dana North Zone and into the Pine Zone prior to recognition of the latter as a separate, differently oriented zone.

2020 Palladium Highlights

Highlights of the Phase 1 2020 drill program are as follows:

– Hole PZ-20-04 intersected 1101 ppb Pd+Pt+Au (1.250 g/t PdEq) over 12 metres from 50 metres downhole, including 1361 ppb Pd+Pt+Au over 8 metres in the Pine Zone; and

– Hole PZ-20-01 intersects 1287 ppb Pd+Pt+Au (1.477 g/t PdEq) over 3 metres from 168 metres downhole in the Pine Zone

Palladium Results

The details of the Phase 1 2020 drill program are presented in Tables 1-2 and Figure 1.
Holes PZ-20-02 and PZ-20-04, -05 and -06 were drilled to expand the Palladium mineralization beyond the 2019 Mineral Resources at the Pine Zone. Hole PZ-20-02 targeted an IP chargeability high and intersected 0.597 g/t PdEq from 125 metres downhole, which expands the mineralization 50 metres along strike to the east from the Mineral Resource Block Model. Holes PZ-20-04, -05 and -06 were drilled to expand the Palladium mineralization up-dip to the north, by 10 metres,
50 metres and 100 metres, respectively. Hole PZ-20-04 targeted an IP chargeability high and intersected 12 metres grading 1.250 g/t PdEq from only 50 metres downhole, including
8 metres at 1.542 g/t PdEq
, and 5 metres grading 0.499 g/t PdEq from 66 metres downhole.
Hole PZ-20-05 intersected 3 metres grading 0.857 g/t PdEq from only 50 metres downhole.
This intersection appears to be slightly more copper rich (Table 2). Hole PZ-20-06 lacked significant assay results but did intersect the breccia unit, the favourable host rock for the Palladium mineralization at River Valley.

Holes T3-20-01, T3-20-02 and PZ-20-03 were drilled to test for the presence of Palladium mineralization where the Pine Zone may be connected at depth to the main River Valley Palladium deposit at the Dana North Zone. Palladium mineralization was intersected in all three holes:
1) Hole T3-20-01 intersected 17 metres grading 0.744 g/t PdEq from 248 metres downhole;
2) T3-20-02 intersected 17 metres of 0.622 g/t PdEq from 318 metres downhole; and 3) PZ-20-03 intersected 0.412 g/t PdEq from 197 metres downhole.

Hole PZ-20-01 was designed to test Palladium grade continuity within the 2019 Mineral Resource Model. PZ-20-01 was collared 50 metres from the nearest previously drilled hole and intersected 3 metres grading 1.477 g/t PdEq from 168 metres downhole. This intersection lies within the Block Model volume of the 2019 mineral resource.


Click Image To View Full Size

* Collar coordinates are UTM NAD83 Zone 17N


Click Image To View Full Size

Notes: 1000 ppb = 1 gram/tonne

The lengths reported are core lengths, but should approximate true widths

nsa = no significant assays

PdEq g/t = Pd g/t + (Pt g/t x 0.89) + (Au g/t x 1.20) + (Cu% x 1.34) + (Ni% x 2.55) + (Co% x 9.01)

For PdEq calculation details, see 2019 Technical Report, “Updated Mineral Resource Estimate and Preliminary Economic Assessment of the River Valley Project”, by P&E Mining Consultants Inc. and DRA Americas Inc.


Click Image To View Full Size

Figure 1. Location of 2020 Phase 1 drill holes (labelled) and previously drilled holes plotted on an inverted IP chargeability image (coloured) and 3-D wireframe model of the Dana North Zone and Pine Zone (covered), River Valley Palladium Project near Sudbury (Ontario, Canada). Note from the inset map that the River Valley Palladium Project is located 60 linear km ENE of the City of Sudbury.

Discussion

The Palladium mineralization at the Pine Zone remains open to expansion by drilling to the east, particularly testing a strong IP chargeability high located about 400 metres along strike, and also by drilling down-dip to the south. Palladium mineralization was also broadly established at the connection of the Pine Zone to the Dana North Zone.

The results of the 2020 Phase 1 drilling bring the cumulative total number of holes intersecting the Pine Zone to 33. The number of Palladium mineralized intersections within the Pine Zone now totals 41, over an area measuring up to 250 metres along strike and 550 metres down-dip.
Note again that the Pine Zone remains open down-dip and particularly to the east, where the most tantalizing IP chargeability high is located.

Assay Procedures & QA/QC

The 2020 Phase 1 drilling was completed by Jacob & Samuel Drilling Ltd. of Sudbury, Ontario under the supervision of NAM geologists. The drill core samples were sent to the SGS Canada Inc. Laboratory in Lakefield, Ontario for sample preparation and assay analyses. The preparation involved crushing of 3 kg of each sample to 90% passing 2 mm, and then pulverizing 0.5 kg to 85% passing 75 um. Palladium, Platinum and Gold were assayed by fire assay with ICP-AES finish (GE-FAI313). Copper, Nickel and 32 additional metals were assayed by two acid digestion and ICP-OES finish (GE-ICP14B). Blanks and blind certified standard samples were submitted at regular intervals for assay with the core samples as part of NAM’s rigorous Quality Assurance/Quality Control program.

Next Steps

NAM is considering its next steps in Palladium exploration and project development at River Valley in 2020. The next steps include any one or a combination of the following activities:

– Analyze significant Palladium core intersections in the Pine Zone for Rhodium;

– Update the 3-D geological modelling of the Pine Zone;

– Carry out further environmental baseline studies (including an archaeological survey);

– Complete Phase 2 drilling, particularly at the priority footwall IP chargeability high,

the Pine Zone-Dana North Zone connection, and down-dip;

– Conduct borehole-IP surveys for off-hole anomalies outside the known resource; and

– Undertake Phase 2 metallurgical studies

The purpose of these activities would be to advance the River Valley Palladium Project and support the Prefeasibility study planned for 2021-22.

About the River Valley Palladium Project

The details of the updated Mineral Resource Estimate (MRE) and Preliminary Economic Assessment (PEA) were announced in the press release dated August 9, 2019 and are described on NAM’s website. The pit constrained Updated Mineral Resource Estimate formed the basis of the PEA. At a cut-off grade of 0.35 g/t PdEq, the Updated Mineral Resource Estimate contains 2.867 Moz PdEq in the Measured plus Indicated classifications and 1.059 Moz PdEq in the Inferred classification. The PEA is a preliminary report, but it demonstrates that there are potentially positive economics for a large-scale mining open pit operation, with 14 years of Palladium production. Refer to the NAM website (www.newagemetals.com) for details.

About NAM

New Age Metals is a junior mineral exploration and development company focused on the discovery, exploration and development of green metal projects in North America.
The Company has two divisions; a Platinum Group Metals division and a Lithium/Rare Element division. The PGM division includes the 100% owned River Valley Project, one of North America’s largest undeveloped Platinum Group Metals Projects, situated 100 km from Sudbury, Ontario and the Genesis PGM Project in Alaska. The Lithium division is the largest mineral claim holder in the Winnipeg River Pegmatite Field where the Company is exploring for hard rock lithium and various rare elements such as tantalum and rubidium. Our philosophy is to be a project generator with the objective of optioning our projects with major and junior mining companies through to production. New Age Metals is a junior resource company on the TSX Venture Exchange, trading symbol NAM, OTCQB: NMTLF; FSE: P7J with 137,347,966 shares issued to date.

Investors are invited to visit the New Age Metals website at www.newagemetals.com where they can review the company and its corporate activities. Any questions or comments can be directed to [email protected] or Harry Barr at [email protected] or Cody Hunt at [email protected] or call 613 659 2773.

Opt-in List

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news.

Qualified Person

The contents contained herein that relate to Exploration Results or Mineral Resources is based on information compiled, reviewed or prepared by Bill Stone, P.Geo., a consulting geoscientist for New Age Metals. Dr. Stone is the Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the technical content of this news release.

On behalf of the Board of Directors

Harry Barr”

Harry G. Barr

Chairman and CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.

Mota Ventures $MOTA.ca Closes $20,000,000 Acquisition of European Pharmaceutical Manufacturer of Natural Psilocybin Extracts $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 7:41 AM on Tuesday, June 2nd, 2020
  • The market for psychedelic derived medicines and therapies is estimated to be as high as USD$100 Billion

VANCOUVER, BC / June 2, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC PINK:PEMTF) (the “Company“) a leading ecommerce provider of CBD products to consumers in the United States and Europe, is pleased to announce the completion of its’ Cdn$20,000,000 acquisition (the “Transaction“) of all of the outstanding share capital of Verrian Ontario Ltd. (“Verrian“) effective June 1, 2020. Verrian is an established and well advanced European psychedelic medicine company that is focused on delivering and developing products related to addiction reduction, with a focus on alcohol and opiates.

Ryan Hoggan, CEO of the Company stated, “The massive shift towards psychedelic derived medicines is no longer in doubt and this acquisition sends a strong signal to the market that Mota Ventures intends to be a serious participant this coming decade. Unlike some companies that use psychedelics as a marketing term, this acquisition of Verrian brings Mota market ready products, world renowned addiction medicine experts, R&D facilities and a 110,000 square foot facility to make it happen. In my opinion this is the most complete psychedelic asset on the market, and therefore should immediately make Mota a market leader in the space.”

Hoggan further added, “In 2020, we have proven our e-commerce ability to acquire tens of thousands of customers and generate millions of dollars in monthly revenues from CBD sales. We intend to bring that same market expertise to bear with our psychedelics business in 2020 and far beyond.”

ACQUISTION PROVIDES MOTA WITH IMMEDIATE ENTRY INTO FAST GROWING $100 BILLION PSYCHEDELICS INDUSTRY

The market for psychedelic derived medicines and therapies is estimated to be as high as USD$100 Billion*. Over the past decade, growing societal awareness and acceptance of mental disorders and addiction as real diseases has accelerated the push for new and innovative treatments using psychedelics, including psilocybin.

As a result, psychedelic research published back in the 50s and 60s has resurfaced and once again highlighted their curative properties. Moreover, the recent legalization of Cannabis in Canada, as well as, across 33 US states for medicinal purposes, has significantly mitigated any stigma, leading to accelerated interest and investment in the psychedelics industry.

Verrian has already developed two psilocybin products that are natural psilocybin extracts, from organically cultivated mushrooms, combined with metabolism enhancing natural herbs. This is only the beginning with further products in various stages of development.

ESTABLISHED EUROPEAN PSYCHEDELIC MEDICINE COMPANY

Verrian owns and operates a 110,000 square foot pharmaceutical manufacturing facility in Radebuel, Germany. Operations within this full suite pharmaceutical manufacturing site include analytical laboratory and finished dose manufacturing, which exceed all international quality standards. The facility and equipment of Verrian have been independently appraised at Cdn$10,600,000 and include an analytical laboratory and full pharmaceutical manufacturing suite.

Verrian operates three distinct business segments:

  • Pharmaceutical Manufacturing – A portfolio of medical & wellness products
  • Phyto API – API creation from medical plants
  • Analytical Testing – European Medicine Agency Standards

PRODUCTS FOCUSED ON OPIATE ADDICTION REDUCTION

Verrian’s singular focus is rewiring the mind to overcome addiction through natural medicine. Specifically, the micro dosing of psilocybin demonstrates potential to remove the dopamine reward of addictive substances, potentially diminishing the desire for addictive substances, thereby reducing or eliminating the need for the addictive substance.

To date Verrian has developed two psilocybin products: PSI GEN and PSI GEN+. These Psilocybin products are focused on opiate addiction reduction. As natural psilocybin extracts, from organically cultivated mushrooms, combined with metabolism enhancing natural herbs, they are ideal for individuals commencing micro-dosing and capable of being combined with additional anti-addiction therapies.

All of Verrian’s compounds are derived from organic, glyphosate free naturally occurring plants, grown specifically for its own purposes.

GOALS AND VISION

In addition to the facility and equipment outlined above, Verrian has invested approximately Cdn$2,400,000 in clinical trial design and development of proprietary formulations for its psilocybin trademarked PSI-GEN products, and cannabis products, including trademarked CBDaily and CBNight.

Verrian’s world renowned addiction medicine experts are moving ahead to develop new potential treatments for therapy, with rigorous clinical research. Once EU GMP and narcotics handling recertification are secured, capabilities will extend to: specialty pharmaceutical formulations; and psilocybin refinement and production for micro dosing.

In consideration for the acquisition of all of the outstanding share capital of Verrian, the Company has issued 54,347,826 common shares (the “Consideration Shares“) to the existing shareholders of Verrian at a deemed price of $0.368 per Consideration Share. 50,543,478 of the Consideration Shares are subject to terms of a thirty-six month time release pooling arrangement, during which time they may not be transferred, assigned, pledged or otherwise traded. The Consideration Shares will be released from the pooling arrangement in tranches, of which ten-percent will be released after four months, fifteen percent after six months, and the balance in five equal tranches every six months thereafter. In addition to the Consideration Shares, upon closing of the Transaction, the Company has arranged for repayment of $150,000 of existing shareholder loans of Verrian, and will arrange for repayment of the balance of $950,000 within sixty days of closing.

The Company is at arms-length from Verrian, and each of its shareholders. The Transaction does not constitute a fundamental change for the Company, nor has it resulted in a change of control of the Company, within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. In connection with completion of the Transaction, the Company has paid a finders’ fee of 5,434,783 common shares to certain arms’-length parties who have assisted in facilitating the Transaction. The Company has also paid an administrative fee of 1,086,957 common shares of the Company to a consultant who assisted with the Transaction.

We encourage shareholders and prospective investors to visit the Company’s AGORACOM Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

About Mota Ventures Corp.

Mota Ventures is an established natural health products company focused in the CBD and psychedelic medicine sectors. Through its powerful eCommerce business, Mota is a leading is a direct-to-consumer provider of a wide range of natural health products throughout the United States and Europe. In the United States, the Company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the United States through its Nature’s Exclusive brand. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom.

Through its German-based Verrian operation, Mota is researching and testing the efficacy and application of natural psilocybin products for the treatment of opioid and other life altering addictions. Mota is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD and other natural health products.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Empower $CBDT.ca #Covid19 Testing Expands to Phase Three and May 2020 Patient Visits Exceed Expectations $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:12 AM on Tuesday, June 2nd, 2020
  • Empower has commenced phase three of COVID-19 testing with a successful pilot of business employee testing
  • Outperforms expected May 2020 patient volume with over 2,300 physician-patient consultations

VANCOUVER BC / June 2nd, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTCQB:EPWCF) (Frankfurt:8EC) (“Empower” or the “Company“), a vertically integrated life sciences company, is pleased to announce that Empower has successfully conducted COVID-19 antibody business employee testing, solidifying the importance of phase three of the testing program. In addition, the Company conducted 2,302 physician-patient consultations setting a new milestone in patient volume for the month of May.

“We established a four-phase approach to the roll-out of COVID-19 testing, ensuring operational excellence throughout the launch”, said Steven McAuley, Chairman & CEO of Empower. “A positive patient experience is imperative to our success, and therefore, establishing precise disciplined pilot programs that are measured, with quantifiable metrics, insure we can scale effectively.”

In an effort to bolster the the Sun Valley Health division, we have hired three new call centre specialists, two new clinic technicians and a full-time phlebotomist… a trained specialist in drawing blood samples for testing.

“During this time of crisis, our team continues to demonstrate patient advocacy and grows stronger in the face of challenges.” said Dustin Klein, SVP Business Development “We continue to see a record number of patients each week, and with the new diversified health and wellness services being offered, we are fortunate to be able to hire new staff.”

Phase One Testing in clinics in Arizona, utilizing a patient blood draw by clinic phlebotomists, then samples are sent to our laboratory test partner for analysis, with test results expected within 48 hours. This program is active and appointment rates are expanding rapidly.

Phase Two Offering a Rapid COVID-19 antibody test with results in 1-15 minutes. The service will be offered in-clinics using a drive-up service, conducted by Company clinic staff. In addition, an outbound door-step service, to support a variety of consumer, patient and community needs will be offered using certified mobile technicians. The online portal is open to book appointments.

Phase Three Business Employee Testing (BET) programs, offering Rapid COVID-19 testing to businesses on a one-time basis, repeat basis and/or subscription basis, to assist businesses to get back to work safely, has been offered. The phase three pilot programs have successfully been delivered establishing a new revenue stream for the Company.

Phase Four U.S. nationwide roll-out, offering all phases of Company services, that can be accessed online at Company websites and call centers, to purchase Rapid COVID-19 test kits. The Company anticipates phase four services to may commence in Q3 2020.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley

Chairman & CEO

[email protected]

604-789-2146

Investors: Dustin Klein

SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws.All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding: the Company’s expected timing of filing of its Annual Filings, the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond; the ability of the Company to complete or execute phases One, Two, Three or Four of COVID-19 test programs, and Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Esports Entertainment Group $GMBL Appoints Industry Veteran Magnus Leppäniemi as VP of Marketing and Head of Esports at Vie.gg $DKNG $PENN $GAN $ESPO

Posted by AGORACOM-JC at 7:08 AM on Tuesday, June 2nd, 2020
  • Announced that Magnus Leppäniemi has joined the Company as Vice President of Marketing and Head of Esports at Vie.gg.
  • Mr. Leppäniemi is a gaming industry veteran and brings more than 20 years of sales and marketing experience

BIRKIRKARA, Malta, June 02, 2020 — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, today announced that Magnus Leppäniemi has joined the Company as Vice President of Marketing and Head of Esports at Vie.gg. Mr. Leppäniemi is a gaming industry veteran and brings more than 20 years of sales and marketing experience.

“Magnus is a proven marketing executive with invaluable knowledge of the gaming and esports industry,” commented Grant Johnson, CEO of Esports Entertainment Group. “Over more than two decades in gaming, Magnus has built an extensive network of relationships that could provide tremendous value as we execute on our global growth strategy.”

Since beginning his career in the gaming industry in 1996, Leppäniemi has sold and managed global esports partnerships for major brands and partners like Intel, BenQ Zowie, Electronic Arts, Activision, ESL, and the NBA. Prior to joining Esports Entertainment Group, Leppäniemi was Global Sales Director for Wehype. Previously, he served as Sales Director North America at DreamHack, a Swedish production company specializing in esports tournaments and other gaming conventions. 

“I’m very excited to join the Esports Entertainment team,” commented Leppäniemi. “As the first online betting company to list on NASDAQ, the Company has a great pedigree that we can continue to build on. We want to build trust with the players, fans, teams, publishers, and the community and give them a unique esports experience. Esports betting is here to stay, and we want to build the premier platform in the industry that benefits the gaming and esports communities. I look forward to accelerating our marketing efforts, refining our go-to-market models, and building out our esports initiatives.”

ABOUT ESPORTS ENTERTAINMENT GROUP

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Malta and Curacao, Kingdom of the Netherlands and is able to accept wagers from over 149 jurisdictions including Canada, Japan, Germany and South Africa. Esports Entertainment offers fantasy, pools, fixed odds and exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company maintains offices in Malta. For more information visit www.esportsentertainmentgroup.com

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations 
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected] 

Media & Investor Relations Inquiries
AGORACOM
[email protected] 
http://agoracom.com/ir/eSportsEntertainmentGroup

MedX Health $MDX.ca Joins AGORACOM Platform For Online Marketing And Verified Discussion Forum For Clean Social Media Engagement With Investors

Posted by AGORACOM-JC at 9:08 PM on Monday, June 1st, 2020
MedX Health Corp. (TSXV: MDX) | LinkedIn
  • Announced the launch of a 12 month online marketing campaign through AGORACOM for the purposes of targeting new potential investors that would be specifically interested in the Company’s primary sectors
  • MedX has also launched “CEO Verified” Discussion Forum on AGORACOM to serve as the Company’s primary social media platform to interact with both current and prospective shareholders in a fully moderated environment

TORONTO, JUNE 1, 2020 —  MedX Health Corp. (“MedX” or the “Company”) (MDX:TSXV), a leading medical device and software company focused on skin cancer detection and telemedicine diagnosis, is pleased to announce the launch of a 12 month online marketing campaign through AGORACOM for the purposes of targeting new potential investors that would be specifically interested in the Company’s primary sectors.  MedX is paying $0 in cash for the program thanks to AGORACOM’s cashless and fully compliant shares for services program.      

SIGNIFICANT EXPOSURE THROUGH AGORACOM DIGITAL NETWORK 

In 2019, AGORACOM surpassed 600 million page views, exceeded industry engagement metrics by over 400% and has served over 350 public companies. 

The MedX HUB containing multiple landing pages, videos, photos and other helpful information updated in real-time over the next 12 months can be found at https://agoracom.com/ir/MDX.   

The MedX HUB will receive significant exposure through continuous brand impression, content marketing, search engine marketing and social media engagement throughout the entire AGORACOM network.  AGORACOM is the only small cap marketing firm to hold a Twitter Verified badge, averaging 4.2 million Twitter impressions per month in 2019. 

MODERATED DISCUSSION FOR MEDX MANAGEMENT AND SHAREHOLDERS 

MedX has also launched “CEO Verified” Discussion Forum on AGORACOM to serve as the Company’s primary social media platform to interact with both current and prospective shareholders in a fully moderated environment. 

AGORACOM “CEO Verified” forums provide the small cap industry’s first ever identity verification of company executives on an investor platform.  For the first time ever, small cap CEO’s and officers can post within a discussion forum without the risk of impersonation.  As the ultimate influencers of their own companies, “CEO Verified” Forums create unmatched levels of engagement between management and investors that create civilized, constructive and factual conversation. 

The MedX Forum can be found at https://agoracom.com/ir/MDX/forums/discussion 

VERIFIED MEDX OFFICER AT LAUNCH 

·         Mike Druhan, VP Corporate Development 

Scott Spean, Chief Executive Officer & President stated, “After receiving the largest order in Company history from our Brazilian distributor earlier this year, it became clear to us the time had arrived to finally start raising our brand awareness amongst small cap investors all over North America.  We expect 2020 to be our commercial breakout year and AGORACOM came highly recommended as the firm best capable of accomplishing this goal. As we build our audience of new investors in 2020, I encourage our long-time and loyal shareholders to read and participate in our new CEO Verified Discussion Forum to create great, vibrant and constructive discussion for the long term benefit of everyone. ” 

George Tsiolis, AGORACOM Founder stated “Fans of AGORACOM know very well that 3rd party validation is a very important element of our decision to take on a client. MedX’s success in Brazil this year, as well as, $3,100,000 raised during the most challenging environment in modern history serves as significant evidence of the Company’s strength.  The additional and more important benefit of knowing we will help save lives of thousands of investors in the future was just too great to give up.  We are happy to take their story to the world and encourage shareholders to do the same by participating and sharing the HUB with their networks.” 

SHARES FOR SERVICES 

The Company intends to issue common shares in the capital of the Company to AGORA in exchange for the Services.  Pursuant to the terms of the Agreement, the Company will be issuing a total fee of $60,000 (plus HST), to be paid as follows:  

TERM:                        May 11, 2020 – May 30, 2021 

  • $12,000 + HST Shares For Services upon Commencement May 11, 2020 for initial set up of HUB, marketing materials and search engine programs.
  • $12,000 + HST Shares For Services at end of Third Month August 11, 2020
  • $12,000 + HST Shares For Services at end of Sixth Month November1 1, 2020
  • $12,000 + HST Shares For Services at end of Ninth Month February 11, 2021
  • $12,000 + HST Shares For Services at end of Twelfth Month May 30, 2021

Per TSX Venture Policy 4.3 (Section 6.1), the deemed price of the securities to be issued will be determined after the date services are provided to advertiser in each period and are to be calculated using the closing price on each date above.

About AGORACOM 

AGORACOM is the pioneer of online marketing, broadcasting, conferences and investor relations services to North American small and mid-cap public companies, with more than 300 companies served. AGORACOM is the home of more than 7.7 million investors that visited 55.2 million times and read over 600 million pages of information over the last 10 years. The average visit of 8min 43sec is more than double that of global financial sites, which can be attributed to the implementation and enforcement of the strongest moderation rules in the industry.

ABOUT MEDX HEALTH CORP.

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin cancer with its SIAscopy on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy™ is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA (US), ARTG and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com.

This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company’s limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company’s projections or forward-looking statements. All forward looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Scott Spearn, President and CEO
MedX Health Corp
905-670-4428 ext 229 

American Creek $AMK.ca Provides Update on Its Annual Filings and First Quarter Filings $TUD.ca $SII.ca $GTT.ca $AFF.ca $SEA.ca $SA $PVG.ca $AOT.ca $ESK.ca

Posted by AGORACOM at 9:10 PM on Friday, May 29th, 2020

AMK: TSX-V, OTCBB: ACKRF

American Creek Resources Ltd. (TSXV: AMK) (the “Company” or “American Creek”) – Following its press release of April 29, 2020, the Company is providing a further update on the status of filing of its annual financial statements, management’s discussion and analysis and related CEO and CFO certificates for the year ended December 31, 2019 (collectively, the “Annual Filings“).

On March 18, 2020, the Canadian Securities Administrators announced that they would provide issuers with a 45-day filing extension for filings required on or before June 1, 2020, as a result of COVID-19 pandemic. As such, the British Columbia Securities Commission has enacted BC Instrument 51-515 Temporary Exemption from Certain Corporate Finance Requirements (“BCI 51-515“).

In its April 29, 2020, press release, the Company announced its reliance on the exemption with respect to extending the deadline of the required filings pursuant to BCI 51-515. The Company currently still expects to file the Annual Filings on or prior to June 15, 2020.

The Company will also rely on BCI 51-515 to extend the deadline of filing its first-quarter consolidated interim financial statements, accompanying management’s discussion and analysis, and related CEO and CFO certificates for the three months ended March 31, 2020 (collectively, the “First-Quarter Filings“), which are required to be filed by June 1, 2020 under sections 4.3 and 4.4 of National Instrument 51-102 – Continuous Disclosure Obligations. The Company is continuing to work diligently and currently expects to have the First-Quarter Filings filed on or prior to the extended filing deadline of July 16, 2020.

As required by BC Instrument 51-515, and similar Instruments and Orders enacted in Alberta, Saskatchewan and Ontario, the Company discloses the following:

  • Until such time as the Company has filed the Annual Filings and the First-Quarter Filings, members of management and other insiders are subject to a trading black-out policy that reflects the principles in section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.
  • The Company confirms that there have been no material business developments, other than those announced through news releases, since November 2019 when the Company filed its third quarter interim financial results for the period ended September 30, 2019.

About American Creek

American Creek is a Canadian junior mineral exploration company with a strong portfolio of gold and silver properties in British Columbia.

Three of those properties are located in the prolific “Golden Triangle”; the Treaty Creek and Electrum joint venture projects with Tudor Gold/Walter Storm as well as the 100% owned past producing Dunwell Mine.

A major drill program was conducted in 2019 at Treaty Creek by JV partner and operator Tudor Gold. The focus of the program was on the Goldstorm zone where drilling has produced very wide intercepts of gold including a 780 meter intercept of 0.683 g/t gold including a higher grade upper portion of 1.095 g/t over 370.5 meters.

The Treaty Creek Project is a Joint Venture with Tudor Gold owning 60% and acting as operator. American Creek and Teuton Resources each have 20% interests in the project. American Creek and Teuton are both fully carried until such time as a Production Notice is issued, at which time they are required to contribute their respective 20% share of development costs. Until such time, Tudor is required to fund all exploration and development costs while both American Creek and Teuton have “free rides”.

A drill program was also recently concluded on the 100% owned Dunwell Mine property located near Stewart. Assay results are pending.

The Corporation also holds the Gold Hill, Austruck-Bonanza, Ample Goldmax, Silver Side, and Glitter King properties located in other prospective areas of the province.

For further information please contact Kelvin Burton at: Phone: 403 752-4040 or Email: [email protected]. Information relating to the Company is available on its website at www.americancreek.com

AGORACOM Welcomes TransCanna $TCAN.ca Developing The largest Multi-Purpose #Cannabis Facility in California, $2M In April Revenues and $24.6M Run Rate From Test Facility $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 2:23 PM on Friday, May 29th, 2020
TransCanna (@TransCanna) | Twitter

(CSE: TCAN) (FSE: TH8)

Why TransCanna?

  • $2M CAD Revenue April 2020
  • $24.6M CAD Revenue Run Rate solely from TransCanna test facility
  • $90M Annual Revenue expected from first full year upon completion of 196,000 Sq Ft Daly facility Q3 2021
  • Daly facility will be one of the largest cannabis facilities in California
  • Recently acquired two California companies,
    • High-end award winning edible producer Soldaze
    • Premium indoor cultivator and distributer Lyfted Farms
  • Lyfted Farms products sold in select Cookies Locations – The most recognizable name in high-end Cannabis.
  • 2019 California Cannabis sales over $3B, industry currently fragmented
  • Direct to dispensary model, cutting out the middleman

THE FACILITY – 196,000 Sq Ft DALY BUILDING

  • Located in Modesto, California; A key asset for TransCanna
  • 196,000 square foot building has an appraised value, prior to licensing and build out, of US $15m.
  • The indicative value once operational, post-licensing and build out is projected at US $80m.
  • Will be the largest multi-purpose cannabis facility in California.
  • Electricity Rates amongst the lowest in California

Daly building will serve as TransCanna’s operations headquarters and will house manufacturing, distribution and cultivation space.

A breakdown of the 196,000 square feet upon completion will be:

  • 45,000 square feet of manufacturing
  • 50,000 square feet of distribution, packaging and cannabis storage
  • 60,000 square feet of indoor cultivation space
  • 5,000 square feet of independent lab for product testing
  • 36,000 square feet of offices, equipment maintenance, employee areas
https://youtu.be/CbZz_yZQ4nE